Astragaloside Ⅳ combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway

Rendong Wei(Qingdao Eighth People's Hospital), Tao Liu(Qingdao Eighth People's Hospital)
Experimental and Therapeutic Medicine
November 13, 2018
Cited by 25


Related Papers